Exelixis (EXEL) announces CONTACT-01 study did not meet its primary endpoint
Go back to Exelixis (EXEL) announces CONTACT-01 study did not meet its primary endpoint| Exelixis, Inc. (NASDAQ: EXEL) | Delayed: 53.21 +0.89 (1.70%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $52.32 | 52 Week High | $17.00 | |||
| Open | $52.32 | 52 Week Low | $3.55 | |||
| Day High | $53.33 | P/E | N/A | |||
| Day Low | $52.11 | EPS | $-1.33 | |||
| Volume | 365,702 | |||||

